By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Maverick Therapeutics 



Brisbane  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Maverick Therapeutics is a private start-up biotechnology company that had been solely financed by MPM Capital. Maverick was spun out of its former parent, Harpoon Therapeutics, Inc., during 2016. Maverick’s novel T-cell engagement format has the potential to eliminate the toxicity challenges inherent in the use of T-cell redirection therapy due to expression of the target antigen on normal tissue. Maverick’s therapeutic antibodies are designed to be inactive upon administration but fully active in the tumor microenvironment. Maverick was founded by Jeanmarie Guenot, Ph.D., MPM founder Luke Evnin, Ph.D., and Patrick Baeuerle, Ph.D., an internationally renowned cancer immunologist and an acknowledged leader in the T-cell redirection field.


YEAR FOUNDED:

2016

LEADERSHIP:

Founders: Jeanmarie Guenot, Ph.D., Luke Evnin, Ph.D., Patrick Baeuerle, Ph.D.

President and CSO: Hans-Peter Gerber, Ph.D.

TECHNOLOGY:

Please click here for Novus' technology.


Key Statistics


Email:
Ownership: Private

Web Site: Maverick Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->